Generation Change 4.0 at Ottobock

Food and Healthcare Press Releases Monday September 18, 2017 08:08
DUDERSTADT, Germany--18 Sep--PRNewswire/InfoQuest
German medtech company sets course for future

Prof. Hans Georg Nader's youngest daughter, Georgia, will in future be representing the family on Ottobock's supervisory board, which is currently being formed. Otto Bock HealthCare GmbH, based in the German state of Lower Saxony, is undergoing the conversion to an SE & Co. KGaA. Georgia Nader will therefore also be enlisted to the executive board of Otto Bock Holding GmbH & Co. KG.

(Photo: http://mma.prnewswire.com/media/556755/Georgia_Nader.jpg )
(Photo: http://mma.prnewswire.com/media/556754/Dr__Oliver_Scheel.jpg )

Following nearly three decades in his role as CEO at Otto Bock HealthCare GmbH, Prof. Hans Georg Nader (56) will be assuming the leadership of the supervisory board of the future Ottobock SE & Co. KGaA as chairman of the board. Dr Oliver Scheel (49) will take over the role of CEO on 15 January 2018.

The appointment of Dr Scheel, a long-time partner and managing director at consulting company A.T. Kearney and head of their pharma, medical technology and healthcare department who possesses extensive expertise in the subject of transformation management, represents the first time in Ottobock's history that a manager from outside the family has taken the helm of the German-based "hidden champion" and global market leader in the field of technical orthopaedics.

Longstanding CFO Harry Wertz (60) will exclusively continue his role as CEO with the Otto Bock Holding GmbH & CoKG.
The head of the Nader Family Office, Stefan Hirsch (45), was also enlisted to the executive board of Otto Bock Holding GmbH & Co. KG as part of the developments within the company.
Further information: http://www.ottobock.com/en/press/press-releases/news-overview-page-2.0.html
Head of Investor Relations / Corporate Communications
Mark C. Schneider
Phone: +49(0)30-398-206-222 / mobile: +49(0)151-146-591-35
Email: MarkC.Schneider@ottobock.de
Source: Otto Bock HealthCare GmbH

Latest Press Release

ESMO Publishes New Position Paper on Supportive and Palliative Care

ESMO, the leading professional organisation for medical oncology, published a position paper on supportive and palliative care [ https://doi.org/10.1093/annonc/mdx757 ], calling attention to the evolving and growing gap between the needs of cancer...

Koch Disruptive Technologies to Lead $150 Million Investment of INSIGHTEC

The medical device company is transforming neurological treatments through its non-invasive focused ultrasound applications Koch Disruptive Technologies, a subsidiary of Koch Industries focused on finding and funding innovative and emerging companies,...

MediaTek Sensio: New Biosensor Solution Brings Health Monitoring to Smartphones

MediaTek Inc. today unveiled MediaTek Sensio(TM), the first 6-in-1 smartphone biosensor module. MediaTek Sensio is a powerful advanced health monitoring solution which makes it easy to track heart rate information, blood pressure trends, peripheral...

Merck Signs Distribution Agreement with Avanti(R) Polar Lipids

Merck , a leading science and technology company, today announced that it has entered into an agreement with Avanti(R) Polar Lipids to be the exclusive multinational distributor of the USA-based company's research lipids portfolio outside of the United...

Xultophy(R) Significantly Reduces Blood Sugar Levels, Body Weight and Risk of Hypoglycaemia for People With Type 2 Diabetes in Real-World Setting

Newly published data from real-world European clinical practice has shown that Xultophy(R) (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with type 2 diabetes after six months.[1] The study looked at people with type 2...

Related Topics